Accelerant Holdings
- Market cap
- 4.29B
- P/E (TTM)i
- -3.13
- P/Bi
- 5.98
- EPSi
- -6.42
- Div yieldi
- 0.00%
- 52W posi
- 99%
Anonymous reader poll. Unscientific, not investment advice.
Valuation each multiple against its own 5-year range
Vs. peers Insurance Brokers
| Company | Market cap | P/E (TTM)i | P/Bi | Div yieldi |
|---|---|---|---|---|
| Accelerant Holdings (ARX) | 4.29B | -3.13 | 5.98 | 0.00% |
| Marsh (MRSH) | 82.87B | 21.20 | 5.46 | 2.07% |
| Arthur J. Gallagher (AJG) | 58.21B | 37.66 | 2.45 | 1.19% |
| Aon PLC (AON) | 57.37B | 14.91 | 5.98 | 1.13% |
| Willis Towers Watson (WTW) | 27.00B | 18.00 | 3.51 | 1.29% |
| Brown & Brown (BRO) | 20.65B | 19.72 | 1.64 | 1.05% |
Other StockVane-tracked companies in the same industry.
Morningstar
Trading 40.5% below Morningstar's fair value estimate.
Fair value
While Accelerant Holdings may seem inexpensive after its substantial price decline over the past year, we've limited its rating to 3 stars to account for the possibility that it may represent a value trap. The stock currently trades at a 29% discount to our quantitative fair value estimate of $27.74 per share; however, caution is warranted due to this estimate's high uncertainty rating.
The company's balance sheet increases our estimated fair value. Leverage can enable a company to invest in growth, potentially boosting shareholder value more than equity financing alone. For example, the firm's EBITDA/interest coverage ratio of -12.8 lies in the bottom 10% compared with global peers. Although the firm's ability to cover interest payments with EBITDA is limited, shares could sharply rebound if economic circumstances change or recent investments reduce fears of default. We believe this is a sign that shares could be undervalued.
Alternatively, the firm's valuation metrics are potentially concerning. A company's valuation metrics provide insights into the market's expectations for its future growth and profitability. The firm's book value yield of 16.8%, a core component of valuation, falls in the bottom 20% compared with peers globally. The market value of this company's shares looks expensive relative to the book (accounting) value of equity, which, despite our favorable price/fair value ratio, is a negative attribute.
Economic moat
With its quantitative economic moat rating of none, this business is unlikely to consistently outearn its cost of capital without structural protection from competition. Additionally, the firm's moderate financial health score suggests it is acceptably positioned against adverse economic circumstances.
By Quantitative Equity Report
Quote time 2026-10-08 06:31:01 · For reference only, not investment advice and not tailored to your situation.